PTPRU and cancer: miR-574-5p is overexpressed in patients with advanced metastatic NSCLC. It promotes both the migration and the invasion of cancer cells as well as enhances the tyrosine phosphorylation of β-catenin by repressing PTPRU expression in vitro.